Plant-based food and beverage company SunOpta (NASDAQ:STKL) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.8% year on year to $193.9 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $790 million at the midpoint. Its non-GAAP profit of $0.06 per share was in line with analysts’ consensus estimates.
Electrical construction and infrastructure services provider MYR Group (NASDAQ:MYRG) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 17.4% year on year to $829.8 million. Its GAAP profit of $0.99 per share was 59% above analysts’ consensus estimates.
Aerospace and defense company Kratos (NASDAQ:KTOS) fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 3.4% year on year to $283.1 million. Next quarter’s revenue guidance of $290 million underwhelmed, coming in 2.1% below analysts’ estimates. Its non-GAAP profit of $0.13 per share was 27.8% above analysts’ consensus estimates.
Personal care company The Honest Company (NASDAQ:HNST) announced better-than-expected revenue in Q4 CY2024, with sales up 10.6% year on year to $99.84 million. Its GAAP loss of $0.01 per share was in line with analysts’ consensus estimates.
Agricultural and farm machinery company Titan (NSYE:TWI) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 1.7% year on year to $383.6 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $475 million at the midpoint, or 1.9% above analysts’ estimates. Its GAAP profit of $2 per share was significantly above analysts’ consensus estimates.
The Asia-Pacific economic and corporate calendar is virtually empty on Thursday, allowing investors to take their cue from global drivers, two of which stand out above all others - Nvidia's earnings and U.S. President Donald Trump's latest musings on tariffs. Nvidia reported fourth-quarter earnings after the market close on Wednesday. Revenue grew 78% to $39.3 billion, beating estimates of $38.04 billion, and the firm's forecast for first-quarter revenue was also above market estimates.
Plant-based protein company Beyond Meat (NASDAQ:BYND) announced better-than-expected revenue in Q4 CY2024, with sales up 4% year on year to $76.66 million. On the other hand, the company’s full-year revenue guidance of $327.5 million at the midpoint came in 1.3% below analysts’ estimates. Its non-GAAP loss of $0.65 per share was 44.3% below analysts’ consensus estimates.
Water management company Northwest Pipe (NASDAQ:NWPX) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 8.6% year on year to $119.6 million. Its GAAP profit of $1 per share was 9.5% above analysts’ consensus estimates.
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6% year on year to $79.61 million. On the other hand, next quarter’s revenue guidance of $79 million was less impressive, coming in 3.5% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was 47.6% below analysts’ consensus estimates.
Salesforce's outlook fell short of analysts’ expectations, sending shares lower in extended trading Wednesday.